Clearstead Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$720	Buy	+642	New	+$720	﹤0.01%	2458
2021 Q4	–	Sell	-12	Closed	-$1K	–	1324
2021 Q3	$1K	Hold	12	–	–	﹤0.01%	1198
2021 Q2	$1K	Buy	+12	New	+$1K	﹤0.01%	1143